Browse articles by sector
Select a sector to explore our curated archive of insights and market intelligence tailored to your specific sector of life science.
Scaling pioneer-led biotechs from early discovery to clinical proof-of-concept, professionalising C-suites, and managing critical founder transitions.
From this category
Universal seasonal flu vaccines are entering late-stage trials. Discover the regulatory affairs leaders needed to navigate these international registration programmes.
Directing drug delivery to targeted tissues remains a major challenge. Sourcing translational scientists specialised in exosome engineering is critical to pipeline validation.
Scaling pioneer-led biotechs from early discovery to clinical proof-of-concept, professionalising C-suites, and managing critical founder transitions.
Securing elite commercial and clinical leaders specialised in targeted therapeutics, orphan drugs, and complex global regulatory approvals.
From this category
The clinical validation of next-generation oncology therapeutics brings hope to difficult-to-treat cancers. Sourcing medical directors specialised in solid tumours is critical.
The shift from injectable to oral GLP-1 formulations is transforming the metabolic sector. Discover the commercialisation capabilities required to lead these multi-billion pound launches.
Securing elite commercial and clinical leaders specialised in targeted therapeutics, orphan drugs, and complex global regulatory approvals.
Repositioning contract developers and service providers as high-value strategic partners through specialised operational and scientific leadership.
From this category
Supply chain vulnerabilities are driving European initiatives to repatriate API production. Discover the manufacturing leaders needed to run highly automated production sites.
The adoption of remote monitoring in clinical-stage research has driven regulators to update trial standards. We discuss the implications for clinical operations directors.
Repositioning contract developers and service providers as high-value strategic partners through specialised operational and scientific leadership.
Placing battle-tested, execution-oriented executives to drive capital efficiency, accelerate commercial milestones, and maximise portfolio value.
From this category
As generalist investors return to life sciences, public boards must professionalise to meet heightened compliance and disclosure standards.
Utilising priority vouchers can shorten regulatory timelines to under two months. We assess how investment partners evaluate the strategic value of regulatory assets.
Placing battle-tested, execution-oriented executives to drive capital efficiency, accelerate commercial milestones, and maximise portfolio value.
Recruiting digital-native leaders to navigate the intersection of clinical validation, regulatory frameworks, and AI-enabled healthcare platforms.
From this category
Using machine learning to identify responsive trial participants reduces patient drop-out and de-risks development timelines. We explore the data-fluent leaders driving this shift.
Integrating digital twin placebo groups can dramatically reduce clinical trial timelines. We outline the data-fluent biostatistics leadership required to secure regulatory sign-off.
Recruiting digital-native leaders to navigate the intersection of clinical validation, regulatory frameworks, and AI-enabled healthcare platforms.
Sourcing specialised leadership to accelerate the clinical development, regulatory approval, and commercial scaling of complex diagnostic systems.
From this category
Integrating biomarkers early in drug development improves patient stratification and trial success. Sourcing diagnostic leaders who understand drug-diagnostic co-development is key.
Rapid diagnostic platforms are shifting healthcare delivery from clinics to patient homes. We explore the commercial leadership needed to scale these diagnostic systems globally.
Sourcing specialised leadership to accelerate the clinical development, regulatory approval, and commercial scaling of complex diagnostic systems.